NLRP3 and periodontal disorder: Metformin, an oral antidiabetic drug, exhibits anti-inflammatory effects by reducing the activity of inflammasomes containing NLRP3, suggesting that anti-inflammatory drugs may be useful in the prevention and treatment of periodontal disease [42].